Epigenomics AG to Present at the 3rd Annual Rodman & Renshaw Global Healthcare Conference in Monte Carlo
May 11, 2006 11:10 ET
|
Epigenomics AG
BERLIN, Germany and SEATTLE, May 11, 2006 (PRIMEZONE) -- The German biotech company Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX) announced today that the company will be presenting at the 3rd...
Epigenomics AG Reports First Quarter 2006 Results
May 03, 2006 02:23 ET
|
Epigenomics AG
BERLIN and SEATTLE, May 3, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today reported financial...
Clinical Study Proves Prognostic Power of Epigenomics' Biomarker in Prostate Cancer
April 05, 2006 11:10 ET
|
Epigenomics AG
BERLIN and SEATTLE, April 5, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today presented data...
Epigenomics Presents Data Confirming Screening for Methylated DNA in Blood as Key to Early Colorectal Cancer Detection
April 03, 2006 13:35 ET
|
Epigenomics AG
BERLIN, April 3, 2006 (PRIMEZONE) -- Epigenomics AG Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today confirmed that...
Epigenomics AG Reports Financial Results for Fiscal Year 2005
March 24, 2006 02:09 ET
|
Epigenomics AG
BERLIN, Germany and SEATTLE, March 24, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today...
Ad hoc: Epigenomics AG Reports Extension of Blood Screening Product Collaboration
March 22, 2006 15:34 ET
|
Epigenomics AG
BERLIN and SEATTLE, March 22, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Other OTC:EPGNF), a molecular diagnostics company developing tests based on DNA methylation, announced today an...
Epigenomics AG to Host Press Conference and Analyst Meeting for 2005 Annual Results
March 17, 2006 09:39 ET
|
Epigenomics AG
BERLIN and SEATTLE, March 17, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Other OTC:EPGNF) will hold a press conference and analyst meeting on March 24, 2006 to present results for the fiscal...
Epigenomics AG Pursuing Development of Tamoxifen Response Test
January 30, 2006 02:41 ET
|
Epigenomics AG
BERLIN and SEATTLE, Jan. 30, 2006 (PRIMEZONE) -- Epigenomics AG (Other OTC:EPGNF) (Frankfurt:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that Roche...
Epigenomics AG adds Regulatory Affairs and Marketing Expertise to Senior Management
January 04, 2006 03:08 ET
|
Epigenomics AG
BERLIN and SEATTLE, Jan. 4, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today the...
Epigenomics Successfully Completes Biomarker Validation Study for Prostate Cancer Classification Test
January 04, 2006 02:11 ET
|
Epigenomics AG
BERLIN and SEATTLE, Jan. 4, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today the...